Stock Comparison
ABT vs BSX
Abbott Laboratories and Boston Scientific Corp side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$192.35B
$73.25B
P/E (TTM)
35.7
20.5
Forward P/E
20.0
15.4
Price/Sales
4.1
3.5
Price/Book
3.7
2.9
EV/EBITDA
18.6
15.1
Dividend Yield
1.66%
—
Profitability
Net Margin
13.91%
17.48%
Operating Margin
18.17%
21.60%
Return on Equity
10.60%
15.30%
Return on Assets
5.33%
6.19%
Growth (YoY)
Revenue Growth
13.00%
7.50%
Earnings Growth
-47.50%
15.10%
Price & Risk
Beta
0.6
0.6
52-Week High
$134.48
$108.14
52-Week Low
$82.56
$42.63
Analyst Target
$118.42
$62.69
Compare ABT and BSX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.